Study on the interaction of Yohimbine with duplex oligonucleotide using spectroscopic and computational tools

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

DNA-interactions with multivalent ligand(s) have increasingly become the subject of substantial research. For several small-molecules with therapeutic-potential, nucleic-acids serve as their primary molecular-target. Such interaction has been shown to affect transcription, and replication, ultimately leading to apoptotic cell-death. Thus, researchers are becoming increasingly interested in understanding ligand-interaction with oligonucleotides making it possible to develop new, DNA-specific drugs. Yohimbe (Yh), a bioactive indole-alkaloid, has been thoroughly investigated for its pharmaceutical qualities, but the mechanism of DNA-binding is still ambiguous. This research adopted computational and multi-spectroscopic methods to investigate the molecular-mechanism between Yohimbine and hairpin-duplex oligonucleotide at physiological-conditions. The occurrence of slight hypochromic and bathochromic deviations in fluorescence intensity indicates that Yh interacts with hairpin-duplex. Employing the McGhee-von Hipple approach, the Scatchard-plot analyses indicated non-cooperative interaction with 10 5 M -1 binding affinities. The temperature-dependent fluorescence data suggested positive entropy and negative enthalpy supporting the exothermic binding. Salt-dependent fluorescence revealed that non-polyelectrolytic forces governed the DNA-ligand association. The findings of the urea-denaturation, dye-displacement, and molecular-docking analysis, iodide-quenching confirmed groove-binding. Therefore, biophysical tools and in silico modeling were utilized to identify the structural-alteration and energetic-profiling of Yh’s interaction with oligonucleotides which can be employed for the development of DNA-targeted therapeutics.

Article activity feed